Qilu Hospital of Shandong University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2018-11-26
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 46
- Registration Number
- NCT03750916
Evaluate the Impact of Arm Abduction and Adduction on the Intravascular Electrocardiograph During PICC Placement and the Tip Location Changes Related to it
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 150
- Registration Number
- NCT03592602
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Evaluation of Antithrombotic STrategies in STEMI Patients in China
- Conditions
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 8000
- Registration Number
- NCT03510832
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 470
- Registration Number
- NCT03189901
- Locations
- 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
🇨🇳Binzhou People's Hospital, Binzhou, Shandong, China
Bone Metastasis on the Survival of Gefitinib Effective Patients
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-05-17
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 265
- Registration Number
- NCT03157310
Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 232
- Registration Number
- NCT03062800
- Locations
- 🇨🇳
Qilu hospital of Shandong University, Jinan, Shandong, China
Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 210
- Registration Number
- NCT03058718
Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 467
- Registration Number
- NCT02955173
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
Chinese Adolescent Registry for Diabetes (CARD) Study
- Conditions
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 1500
- Registration Number
- NCT02950272
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan Shi, Shandong, China
Retrospective Study of Acute Chest Pain in Extremely Critical Condition for More Than Ten Years
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 7000
- Registration Number
- NCT02837120
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
© Copyright 2024. All Rights Reserved by MedPath